Skip to main content
. 2012 May 14;18(5):341–362. doi: 10.1089/ten.teb.2012.0080

Table 2.

Recent Applications of Raw Material Strategies for In Vivo Bone Tissue Engineering Applications

Reference(s) Raw material(s) Additional material(s) Scaffold formulation Animal model Highlighted finding
Bae et al.80 HA Simvastatin Hydrogel New Zealand white rabbits, parietal bone defect model Hydrogels loaded with simvastatin significantly increased new bone formation after 9 weeks
Chen et al.82 HA, collagen type I (bovine) Bioactive glass, phosphatidylserine Porous composite New Zealand white rabbits, radial defect model Composite scaffold promoted new bone formation and new blood vessel formation after 12 weeks compared to the control (sham) which displayed little new bone formation
Xu et al.78 HA, collagen type I (bovine) Bioactive glass, phosphatidylserine Porous composite Sprague-Dawley rat, femoral defect model Composite scaffolds seeded with MSCs enhanced greater new bone formation compared with control scaffolds with no seeded cells after 6 weeks
Patterson et al.79 HA HA-GMA Hydrogel Sprague-Dawley rat, critical-sized calvarial defect model Codelivery of BMP-2 and VEGF from hydrogels showed improved new bone formation after 6 weeks compared with either of the proteins when delivered alone
Rentsch et al.99 CS, collagen type I (porcine) PCL Porous composite Athymic nude mice, critical-sized femoral defect model PCL meshes coated with CS/collagen type I and seeded with rat MSCs showed significantly increased new bone formation and new blood vessel formation after 12 weeks
Lee et al.156 HAp, human DBM Porous composite Athymic nude rat, intramuscular abdominal pouch model DBM/HA putty induced ectopic mineralized bone formation after 8 weeks, HA granules alone (control) showed limited mineralization
Liu et al.109 nHAp, collagen type Ia PLA Porous composite New Zealand white rabbits, segmental critical-sized alveolar bone defect model nHAp–collagen type I–PLA scaffolds seeded with rabbit DPSCs and cultured with BMP-2 prior to implantation promoted new bone formation after 12 weeks
Teixeira et al.102 HAp, collagen type I (bovine) Porous matrix Immune-deficient mice, subcutaneous implantation model HAp scaffolds seeded with human MSCs showed that those with a collagen coating tended to have a negative effect on bone formation regardless of collagen crosslinking method after 6 weeks
Yeo et al.119 TCP PCL, NaOH Porous composite New Zealand white rabbits, calvarial defect model PCL-TCP scaffolds treated with NaOH for 48 hours to increase surface roughness showed superior bone formation after 8 weeks
Yanoso-Scholl et al.123 TCP PLA Porous composite C57BL/6 mice, intramuscular quadriceps implantation Scaffolds loaded with BMP-2 and VEGF promoted new blood vessel formation but limited mineralization after 8 weeks
Rojbani et al.174 TCP, HAp Porous matrix Wistar rat, calvarial defect model TCP promoted greater bone regeneration after 8 weeks, the addition of simvastatin increased bone formation in all groups
Rai et al.118 TCP PCL Porous composite CBH/Rnu rats, critical-sized femoral defect model Composites seeded with human MSCs showed new bone formation after 3 weeks compared with limited bone formation in scaffolds seeded with no cells
Hao et al.125 TCP, collagen type I (bovine) PLGA Composite hydrogel Japanese white rabbits, critical-sized segmental radial defect Higher cell numbers of rabbit ASCs encapsulated within the scaffold led to enhanced osteogenesis and bone union after 24 weeks
Ghanaati et al.115 TCP Granules with varying size and porosity Wistar rat, subcutaneous implantation model Higher porosity led to greater new blood vessel formation near the center of the construct over 60 days
Ghanaati et al.129 TCP, HA Methylcellulose Injectable bone paste Wistar rat, subcutaneous implantation model The addition of HA and methylcellulose resulted in a formable material to fill in bone defects and led to higher vascularization after 60 days
Cao et al.124 TCP, HAp PGA Porous composite Sprague-Dawley rat, critical-sized femoral defect PGA–TCP scaffolds in a 1:3 ratio provided the greatest new bone formation after 90 days
Eleftheriadis et al.157 TCP, human DBM Hydroxyl sulfate Porous composite New Zealand white rabbits, mandibular defect model TCP–hydroxyl sulfate scaffolds resorbed more slowly than DBM putty over 8 weeks, making them a potential candidate for larger, critical-sized defects
Fujita et al.127 TCP Gelatin Sponge Nihon white rabbits, segmental bone defect model No significant difference was found in new bone regeneration between gelatin–TCP sponge and the BMP-2-loaded gelatin–TCP sponge after 8 weeks
Tadokoro et al.128 TCP Gelatin Sponge Fisher rats, subcutaneous implantation model TCP–gelatin sponges loaded with BMP-2 and seeded with MSCs showed significant new bone formation compared with nonloaded scaffolds and scaffolds with no cells after 4 weeks
Abbah et al.116 TCP PCL Porous composite Yorkshire pigs, spinal interbody fusion model PCL–TCP scaffolds seeded with autogenous MSCs showed new bone formation after 3 months and fusion was observed after 6 months, no fusion occurred in control samples with no seeded cells
Chen et al.153 Bovine DBM Porous matrix Sprague-Dawley rat, subcutaneous implantation model Heparin-crosslinked DBM loaded with VEGF promoted new blood vessel formation superior to unloaded and noncrosslinked scaffolds after 3 weeks
Kang et al.158 Human DBM Fibrin glue Composite glue Miniature pig, maxillary sinus floor implantation model Enhanced new bone activity was observed in the cell-seeded scaffold sites compared with the scaffold-only regions after 4 weeks
Rhee et al.154 Human DBM PLA Porous composite Sprague-Dawley rat, critical-sized calvarial defect model DBM seeded with SVF cells promoted greater new bone formation than groups containing PLA and those without cells after 8 weeks
Supronowicz et al.155 Human DBM Porous matrix Athymic nude rat, intramuscular abdominal pouch model DBM seeded with human ASPSCs provided significantly greater new bone formation after 14 days
a

Collagen species not specified.

nHAp, nanohydroxyapatite; HA-GMA, glycidyl methacrylate modified hyaluronic acid; NaOH, sodium hydroxide; PGA, poly(glycolic acid); SVF, human stromal vascular fraction.